Adient (ADNT) Price Target Raised to $31 by Deutsche Bank and Stifel
Published on 5/13/2026

AI Summary
Summarized by AI from the source belowDeutsche Bank raised its price target for Adient plc (ADNT) to $31 from $30 while maintaining a Buy rating. Stifel also increased its price target on ADNT to $28 from $26. On May 6, 2026, Adient reported Q2 adjusted EPS of $0.52, exceeding the consensus estimate of $0.44, with revenue of $3.87 billion compared to a $3.63 billion estimate. Additionally, Adient raised its FY26 revenue outlook to $14.8 billion, adjusted EBITDA outlook to $885 million, and free cash flow to $130 million, underscoring strong operational execution.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Earnings
Cardinal Health Raises Price Target After Positive Profit Guidance
Aug 11

Earnings
Hnit-Baltic Uab Announcement: Financial Performance Updates
Aug 11

Earnings
Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments
Aug 11

Earnings
Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth
Aug 11